Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 21, 2024

BUY
$48.48 - $57.85 $40.1 Million - $47.9 Million
827,606 New
827,606 $42.5 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $31.7 Million - $35.2 Million
497,017 Added 16661.65%
500,000 $32 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $47.8 Million - $54.2 Million
-727,017 Reduced 99.59%
2,983 $206,000
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $48.6 Million - $57.6 Million
709,741 Added 3503.34%
730,000 $52.5 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $9,241 - $5.46 Million
-71,085 Reduced 77.82%
20,259 $1.44 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $6.63 Million - $7.31 Million
91,344 New
91,344 $7.03 Million
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $35 Million - $41.9 Million
-568,600 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $14.5 Million - $16.9 Million
-270,075 Reduced 32.2%
568,600 $35.5 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $1.6 Million - $1.87 Million
27,038 Added 3.33%
838,675 $49.6 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $40.7 Million - $44.4 Million
657,830 Added 427.7%
811,637 $54.2 Million
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $23.7 Million - $26.6 Million
-399,093 Reduced 72.18%
153,807 $9.71 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $26 Million - $29.4 Million
450,098 Added 437.83%
552,900 $34.3 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $85 Million - $94.2 Million
-1,479,576 Reduced 93.5%
102,802 $6.2 Million
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $86.1 Million - $101 Million
1,570,776 Added 13538.84%
1,582,378 $93 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $77,302 - $112,338
-1,666 Reduced 12.56%
11,602 $647,000
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $652,918 - $851,672
13,268 New
13,268 $852,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Healthcare Of Ontario Pension Plan Trust Fund Portfolio

Follow Healthcare Of Ontario Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.